Lupin has built on a recent alliance in China with Foncoo by agreeing a further partnership for the Chinese market, this time with Yabao Pharmaceutical.
Lupin has announced the next step in its plans to venture into the Chinese market in the form of a strategic partnership with China’s Yabao Pharmaceutical.
While the specific terms of the deal were not disclosed, Lupin said that the partnership would initially aim to “meet...
Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
